文献速递流行病学与生物统计医学教育与科研方法

儿童健康随机对照试验中患者与公众参与的发生率及其对研究质量、失访和传播的影响

Prevalence of patient and public involvement in child health randomized controlled trials and impact on research quality, loss to follow-up, and dissemination.
PubMed 文献 · J Clin Epidemiol · 2025-06-02

该文献计量分析从2021至2023年Cochrane系统评价库中随机选取199项儿童健康随机对照试验,比较有患者与公众参与(PPI+)与无参与(PPI-)试验的研究质量、失访和传播。仅12/199(6%)报告PPI。非整群RCT中PPI+失访率高于PPI-(15% vs 5%,P=0.03),整群RCT中则较低(0% vs 2%,P=0.05);研究质量相似(42% vs 29%评为好/一般,P=0.34);PPI+的PlumX年度捕获数更高(18.2 vs 11.9,P=0.02)。结论认为PPI不常见,可能适度促进传播,但报告缺乏标准化限制分析。

要点

  • 儿童健康RCT中仅6%(12/199)报告了患者与公众参与(PPI)。
  • PPI+与PPI-试验的研究质量相似(42% vs 29%评为好/一般,P=0.34)。
  • PPI+试验的PlumX年度捕获数高于PPI-(18.2 vs 11.9,P=0.02)。

核心结论

  • 儿童健康RCT中PPI不常见;PPI+与PPI-试验研究质量相似;PPI可能适度促进研究结果传播;PPI报告缺乏标准化导致描述不一致、潜在错误分类并阻碍明确分析其影响,需要改进PPI报告。

研究设计与样本

  • 文献计量分析,纳入2021至2023年Cochrane系统评价库中所有儿童健康干预评价,从每个符合标准的系统评价中随机选取一项RCT,共199项试验;两名独立评价者将试验分类为PPI+或PPI-并收集相关变量数据。

主要发现

  • 仅12/199项RCT(6%)报告了研究过程中的PPI。
  • 非整群RCT中,PPI+试验的失访率高于PPI-试验(15% vs 5%,P=0.03)。
  • 整群RCT中,PPI+试验的失访率低于PPI-试验(0% vs 2%,P=0.05)。
  • PPI+与PPI-试验的研究质量相似(42% vs 29%评为好/一般,P=0.34)。
  • PPI+试验的PlumX年度捕获数(书签、收藏、读者、关注)高于PPI-试验(18.2 vs 11.9,P=0.02)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • PPI报告缺乏标准化导致描述参与情况不一致、研究中PPI潜在错误分类,并阻碍对PPI影响的明确分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Patient and public involvement (PPI) in randomized controlled trials (RCTs) is hypothesized to enhance research quality, participant enrollment and retention, and uptake of findings. However, there are few empirical data on the impact of PPI in child health RCTs. Our objective was to compare research quality, loss to follow-up, and dissemination for child health RCTs with PPI in the research process (PPI+) with trials that did not (PPI-). STUDY DESIGN AND SETTING: In this bibliometric analysis, all child health intervention reviews in the Cochrane Library of Systematic Reviews between 2021 and 2023 were identified. One RCT from each eligible systematic review was randomly selected, generating a sample of 199 individual trials. Two independent reviewers classified trials as PPI+ or PPI- and collected data on variables of interest. RESULTS: Only 12/199 RCTs (6%) reported PPI in the research process. Percent lost to follow-up was higher in PPI+ trials compared to PPI- trials among noncluster RCTs (15% vs. 5%; P = .03), but lower for cluster RCTs (0% vs. 2%, respectively; P = .05). Research quality was similar for PPI+ and PPI- trials (42% vs. 29%, respectively, were rated as "good/fair"; P = .34). Both academic and nonacademic measures of dissemination were modestly higher for PPI+ trials compared with PPI- trials. Specifically, PlumX Captures per year (bookmarks, favorites, readers, follows) were higher for PPI+ trials compared with PPI- trials (18.2 vs. 11.9, respectively; P = .02). CONCLUSION: PPI was infrequent among child health RCTs. Research quality was similar for PPI+ and PPI- trials. PPI may modestly enhance dissemination of research findings. The lack of standardized reporting of PPI leads to inconsistency in describing involvement, potential misclassification of PPI in research, and prevents the definitive analysis of the impact of PPI. Improved reporting of PPI in child health RCTs is needed. PLAIN LANGUAGE SUMMARY: Patient and public involvement (PPI) in health research refers to researchers working together with patients and other members of the public on any or all aspects of a research study. For our study, we compared research quality, loss to follow-up, and dissemination (ie, sharing of research findings) for child health randomized controlled trials (RCTs) with PPI in the research process with trials without PPI. We searched the Cochrane Library of Systematic Reviews for all child health intervention reviews published between 2021 and 2023 and randomly selected one RCT from each systematic review, creating a sample of 199 individual trials. Two reviewers classified trials as PPI+ or PPI- and collected data on variables of interest. We found that PPI in child health RCTs was uncommon (12/199, 6%), but PPI+ RCTs had similar research quality and improved dissemination compared to PPI- RCTs.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Akbar S, Borkhoff CM, Hattangadi N, et al. Prevalence of patient and public involvement in child health randomized controlled trials and impact on research quality, loss to follow-up, and dissemination. J Clin Epidemiol. 2025. PMID: 40467012. doi:10.1016/j.jclinepi.2025.111858

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。